AACP
LMAT icon

Advantage Alpha Capital Partners’s LeMaitre Vascular LMAT Stock Holding History

Advantage Alpha Capital Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-63,608
Closed -$1.58M – 94
2020
Q1 		$1.58M Buy
+63,608
New +$1.96M 0.56% 84

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Advantage Alpha Capital Partners's LMAT Position: Q2 2020 in Review

Advantage Alpha Capital Partners sold out of LeMaitre Vascular (LMAT) in Q2 2020, closing a stake of 63,608 shares — an estimated $1.58M sold.

Advantage Alpha Capital Partners first reported a position in LMAT in Q1 2020 and held it in 1 quarter. The position peaked at $1.58M in Q1 2020. 147 funds tracked by Wall St. Rank hold LMAT as of Q2 2020.

  • Advantage Alpha Capital Partners reported no remaining LeMaitre Vascular position as of Q2 2020 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 63,608 LeMaitre Vascular shares in Q2 2020, an estimated $1.58M.
  • Advantage Alpha Capital Partners first reported a position in LeMaitre Vascular in Q1 2020 and held it in 1 quarter.
  • Advantage Alpha Capital Partners's LeMaitre Vascular position peaked at $1.58M in Q1 2020.
  • 147 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2020.

Based on Advantage Alpha Capital Partners's 13F filing for Q2 2020, filed 13 Aug 2020.